Warning!
Your browser does not support HTML5.
Display of the content may be incorrect. Please make sure that your browser supports HTML5 syntax.
Search for Small Molecules by SMILES, name, CAS, MFCD, ID, InChI Key
Search for Biologics by ID, Target name, CAS, Protein name, Gene ID, Clone ID, Source Organism
0
0.00 $
Currency
Home CSSS00161188994

Structure Info

Chemspace ID
CSSS00161188994 (In-Stock Screening Compounds)
MFCD
MFCD32201050
IUPAC Name
8-{4'-[4-(methoxycarbonyl)benzamido]-[1,1'-biphenyl]-4-amido}naphthalene-1-sulfonic acid
Mol formula
C32H24N2O7S
Mol weight
581 Da
Catalog Number(s)
A1251847, AA01MVN2, ADB4136294001, AG01MVPU, AR01MWEU, BB46954, BD01176059, BJ46954, CSC161188994, G16976, HY-120323, M26176, MS-30417, SM00963, T11096, Y1258100, Y1462073, Y226082, ZXC193507, ZXC281565

Properties

LogP
5.98
Heavy atoms count
42
Rotatable bond count
8
Number of rings
5
Carbon bond saturation, Fsp3
0.031
Polar surface area (Å)
139
Hydrogen bond acceptors count
6
Hydrogen bond donors count
3

SDS

Choose Language:

If you wish to request SDS before ordering, please contact us at [email protected]

C32H24N2O7S
Zoom the structure
CSSS00161188994
 

Items Overall 14 items from 3 suppliers

SupplierLead timeShips fromPurityPackPrice, $Qty
MedChemExpress10 daysUnited States
To:
995 mg90
Go to cartEnquire
MedChemExpress10 daysUnited States
To:
9910 mg150
Go to cartEnquire
MedChemExpress10 daysUnited States
To:
9950 mg500
Go to cartEnquire
MedChemExpress10 daysUnited States
To:
99100 mg750
Go to cartEnquire
Description: Names: DRI-C21045; Product Description: DRI-C21045 (compound 10) is a potent and selective inhibitor of the CD40-CD40L costimulatory protein-protein interaction (PPI) with an IC 50 of 0.17 μM. DRI-C21045 shows concentration-dependent inhibition of the activation of NF-κB and B cell proliferation all induced by CD40L with IC 50 s of 17.1 μM and 4.5 μM, respectively .; Target: TNF Receptor; CAS: 2101765-81-3
MedChemExpress EU10 daysSweden
To:
985 mg95
Go to cartEnquire
MedChemExpress EU10 daysSweden
To:
9810 mg158
Go to cartEnquire
MedChemExpress EU10 daysSweden
To:
9850 mg527
Go to cartEnquire
MedChemExpress EU10 daysSweden
To:
98100 mg790
Go to cartEnquire
Description: Names: DRI-C21045; Product Description: DRI-C21045 (compound 10) is a potent and selective inhibitor of the CD40-CD40L costimulatory protein-protein interaction (PPI) with an IC50 of 0.17 μM. DRI-C21045 shows concentration-dependent inhibition of the activation of NF-κB and B cell proliferation all induced by CD40L with IC50s of 17.1 μM and 4.5 μM, respectively; Target: TNF Receptor; CAS: 2101765-81-3
Targetmol Chemicals Inc30 daysUnited States
To:
985 mg43
Go to cartEnquire
Targetmol Chemicals Inc30 daysUnited States
To:
9810 mg73
Go to cartEnquire
Targetmol Chemicals Inc30 daysUnited States
To:
9825 mg139
Go to cartEnquire
Targetmol Chemicals Inc30 daysUnited States
To:
9850 mg248
Go to cartEnquire
Targetmol Chemicals Inc30 daysUnited States
To:
98100 mg371
Go to cartEnquire
Targetmol Chemicals Inc30 daysUnited States
To:
98200 mg527
Go to cartEnquire
Description: Dri-c21045 showed concentration-dependent inhibition of NF-kB activation and all CD40L induced by B cell proliferation with IC50 of 17.1 μM and 4.5 μM, respectively. Dri-c21045 is an effective selective inhibitor of CD40-CD40L synergistic stimulator protein-protein interaction (PPI) with IC50 of 0.17 μM.; CAS: 2101765-81-3
For a custom pack size or bulk
please drop us a line:Enquire